Targeting Tumor Lymphangiogenesis: An Update
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
698-708
Author(s):
M. Raica and D. Ribatti
Molecular Bases of Liver Cancer Refractoriness to Pharmacological Treatment
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
709-740
Author(s):
J. J.G. Marin, M. R. Romero and O. Briz
Valproic Acid in the Complex Therapy of Malignant Tumors
Journal:
Current Drug Targets
Volume:
11
Page:
361-379
Author(s):
J. Hrebackova, J. Hrabeta and T. Eckschlager
Recent Advances and Future Directions in the Management of Metastatic Renal Cell Carcinoma
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
225-235
Author(s):
J. Ansari, J. Glaholm, R. McMenemin, N.D. James and S.A. Hussain
Silibinin – A Promising New Treatment for Cancer
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
186-195
Author(s):
Catherine Wing Ying Cheung, Norma Gibbons, David Wayne Johnson and David Lawrence Nicol
Toll-Like Receptors: Cost or Benefit for Cancer?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1081-1090
Author(s):
T. Matijevic and J. Pavelic
Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1159-1166
Author(s):
David L. Vesely
Antitumor Activities of Interleukin-27 on Melanoma
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
10
Page:
41-46
Author(s):
Hiroshi Nagai, Shuntaro Oniki, Susumu Fujiwara, Mingli Xu, Izuru Mizoguchi, Takayuki Yoshimoto and Chikako Nishigori
Characterization of Molecular and Functional Alterations of Tumor Endothelial Cells to Design Anti-Angiogenic Strategies
Journal:
Current Vascular Pharmacology
Volume:
8
Page:
220-232
Author(s):
Benedetta Bussolati, Maria Chiara Deregibus and Giovanni Camussi
Raf Inhibitors as Therapeutic Agents Against Neurodegenerative Diseases
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
9
Page:
120-127
Author(s):
Sarah Burgess and Valentina Echeverria